Guest guest Posted December 11, 2008 Report Share Posted December 11, 2008 I have not used Nebido, but I have heard about it from men in Europe, and there seems to be a consensis that it does not last as long as it is advertised to. The men that I have coresponded with said that the nebido injections are only lasting three months before they start to fall below targeted levels, Second, Nebido is merely testosterone undecanote, and this particular testosterone ester has been around for a long time. The pill form of testosterone undecanote is called andriol and it has been around for close to 20 yrs or more. I see the real future of treating secondary hypogonadism as a diabetic like pump that administers LH and FSH in such away to simulate the pituitary's natural cycles and normal HPTA function > > Was reading a book on hypogonadism - Jockenhovel, F., and Schubert, M. > (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty recent > and it stated Nebido will be the standard treatment for hypogonadism > because it has favourable effects with regards to libido, bones and > muscle mass, low incidence of side effects and is more stable therefore > avoiding the peaks and troughs normally seen with shorter acting > injectables. > > Also more acceptable to users because only needs to be injected 4/5 > times a year as opposed to 26-52 times - quite a difference. Probably > its biggest selling point! > > However since its market launch in 2004 in Europe it does not seem to > be the market leader and I do not hear of many people using it. Anyone > know why this is? > > Anyone got good/bad experiences on it they can share? > > I know the FDA is currently working with Indevus Pharmaceuticals > (license for Nebido bought from Bayer Schering Pharma) and has been > unhappy with some respiratory side effects in few users (at least 1/100 > people) and therefore wants the company to suggest and implement ways > to reduce these effects before an FDA license will be granted for US > market release. > > Will be interesting to see how this one develops. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 11, 2008 Report Share Posted December 11, 2008 It's great for raising your libido. I am horny 24/7 on it! Pity I don't have the energy or indeed the men with whom to share it! I'm not so sure about the bones. Since starting on Nebido in 2004 I have developed Osteoporosis, Sero negative Arthritis and a mysterious muscle wasting condition. I know that Osteoporosis and Arthritis are common in XXY's - Klinefelters Syndrome, but I reckon that the high level of Testo in my system may be the cause of the muscle waste. I'm not exactly sure what my level of Testo is, but I do know that it's around 8 times higher than the average XY male, bearing in mind that Nebido contains 1000mg in a 4ml solution. You are also correct about it levelling out the Peaks and Troughs associated with other forms of treatment. I spent nearly 30 years of my life suffering from depression. The latter 10 years I was on the Testo pellets, sub-cutaneously implanted every 3 months. I then spent the next 5 years trying out different injectable doses and frequencies. I also tried Androgel. The Peaks and Troughs were dreadful. These disappeared completely once I went onto Nebido. For those of us with Klinefelters, I find that it does trail off somewhat toward the end of the 12 week cycle and for about 2 - 3 weeks before the next shot, I often have great difficulty staying awake. The flipside of that is the difficulty I have getting to sleep throughout the 2nd to 5th week following the shot. It also may be responsible (or rather TRT in general) for making my skin itch, but try telling that to a medic, Most just dismiss it out of hand. Getting the shot itself I find quite painful. It's not painful at the injection site, but I always get a dull pain travelling down my leg into my toes and that usually remains in my foot for several hours. The shot doesn't bother me, but it does seem to bother the nurses who administer it as it takes a while to inject it because of the thick carrier oil (Castor Oil). However speaking for myself, it's by far the best form of TRT I've ever experienced and I've been getting T one way or another for 21 years. Like any drug it does have good and bad side effects. I think I have tried all forms of delivery throughout the 21 years since dx in 1987. Steph Glasgow From: chrisdl2008 <chrisdl2008@...> Subject: Nebido - future market leader? Date: Thursday, 11 December, 2008, 9:12 PM Was reading a book on hypogonadism - Jockenhovel, F., and Schubert, M. (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty recent and it stated Nebido will be the standard treatment for hypogonadism because it has favourable effects with regards to libido, bones and muscle mass, low incidence of side effects and is more stable therefore avoiding the peaks and troughs normally seen with shorter acting injectables. Also more acceptable to users because only needs to be injected 4/5 times a year as opposed to 26-52 times - quite a difference. Probably its biggest selling point! However since its market launch in 2004 in Europe it does not seem to be the market leader and I do not hear of many people using it. Anyone know why this is? Anyone got good/bad experiences on it they can share? I know the FDA is currently working with Indevus Pharmaceuticals (license for Nebido bought from Bayer Schering Pharma) and has been unhappy with some respiratory side effects in few users (at least 1/100 people) and therefore wants the company to suggest and implement ways to reduce these effects before an FDA license will be granted for US market release. Will be interesting to see how this one develops. ------------------------------------ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 11, 2008 Report Share Posted December 11, 2008 As far as I am aware it's supposed to last only 3 months. Mine are every 12 weeks. Steph From: sbryant511 <sbryant511@...> Subject: Re: Nebido - future market leader? Date: Thursday, 11 December, 2008, 10:56 PM I have not used Nebido, but I have heard about it from men in Europe, and there seems to be a consensis that it does not last as long as it is advertised to. The men that I have coresponded with said that the nebido injections are only lasting three months before they start to fall below targeted levels, Second, Nebido is merely testosterone undecanote, and this particular testosterone ester has been around for a long time. The pill form of testosterone undecanote is called andriol and it has been around for close to 20 yrs or more. I see the real future of treating secondary hypogonadism as a diabetic like pump that administers LH and FSH in such away to simulate the pituitary's natural cycles and normal HPTA function > > Was reading a book on hypogonadism - Jockenhovel, F., and Schubert, M. > (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty recent > and it stated Nebido will be the standard treatment for hypogonadism > because it has favourable effects with regards to libido, bones and > muscle mass, low incidence of side effects and is more stable therefore > avoiding the peaks and troughs normally seen with shorter acting > injectables. > > Also more acceptable to users because only needs to be injected 4/5 > times a year as opposed to 26-52 times - quite a difference. Probably > its biggest selling point! > > However since its market launch in 2004 in Europe it does not seem to > be the market leader and I do not hear of many people using it. Anyone > know why this is? > > Anyone got good/bad experiences on it they can share? > > I know the FDA is currently working with Indevus Pharmaceuticals > (license for Nebido bought from Bayer Schering Pharma) and has been > unhappy with some respiratory side effects in few users (at least 1/100 > people) and therefore wants the company to suggest and implement ways > to reduce these effects before an FDA license will be granted for US > market release. > > Will be interesting to see how this one develops. > ------------------------------------ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 12, 2008 Report Share Posted December 12, 2008 All the guys I have spoken too have done very poorly on Nebido and changed to other treatments they have felt better on. Just goes to show you it is a case of horses for courses and what works for one person doesn't work for another and vice versa. The dosage of Nebido is HUGE and I feel this is to benefit the treating clinician not the patient. You get a huge overdose of testosterone at the peak and that results in insomnia. Even though undecanoate doesn't readily convert to estradiol, the size of the dose often results in high E2 levels. That can mean itching skin, gynecomastia and emotional issues especially neaer to the next dose with low testosterone levels. I do not think it will succeed in the US where patient choice is the key issue. Not enough patients will like it. > From: chrisdl2008 <chrisdl2008@...> > Subject: Nebido - future market leader? > > Date: Thursday, 11 December, 2008, 9:12 PM > > Was reading a book on hypogonadism - Jockenhovel, F., and Schubert, M. > (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty recent > and it stated Nebido will be the standard treatment for hypogonadism > because it has favourable effects with regards to libido, bones and > muscle mass, low incidence of side effects and is more stable therefore > avoiding the peaks and troughs normally seen with shorter acting > injectables. > > Also more acceptable to users because only needs to be injected 4/5 > times a year as opposed to 26-52 times - quite a difference. Probably > its biggest selling point! > > However since its market launch in 2004 in Europe it does not seem to > be the market leader and I do not hear of many people using it. Anyone > know why this is? > > Anyone got good/bad experiences on it they can share? > > I know the FDA is currently working with Indevus Pharmaceuticals > (license for Nebido bought from Bayer Schering Pharma) and has been > unhappy with some respiratory side effects in few users (at least 1/100 > people) and therefore wants the company to suggest and implement ways > to reduce these effects before an FDA license will be granted for US > market release. > > Will be interesting to see how this one develops. > > > > ------------------------------------ > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 12, 2008 Report Share Posted December 12, 2008 In late 05 or early 06 I was adked if I would like to be in the Nebido trial. I almost got in but my history of Sleep Apena kept me out. After the trial was over I asked the doctor about the results. He said that it did not work as expected and that it probally would not reach market in the US. Jack > > From: chrisdl2008 <chrisdl2008@> > > Subject: Nebido - future market leader? > > > > Date: Thursday, 11 December, 2008, 9:12 PM > > > > Was reading a book on hypogonadism - Jockenhovel, F., and Schubert, M. > > (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty recent > > and it stated Nebido will be the standard treatment for hypogonadism > > because it has favourable effects with regards to libido, bones and > > muscle mass, low incidence of side effects and is more stable therefore > > avoiding the peaks and troughs normally seen with shorter acting > > injectables. > > > > Also more acceptable to users because only needs to be injected 4/5 > > times a year as opposed to 26-52 times - quite a difference. Probably > > its biggest selling point! > > > > However since its market launch in 2004 in Europe it does not seem to > > be the market leader and I do not hear of many people using it. Anyone > > know why this is? > > > > Anyone got good/bad experiences on it they can share? > > > > I know the FDA is currently working with Indevus Pharmaceuticals > > (license for Nebido bought from Bayer Schering Pharma) and has been > > unhappy with some respiratory side effects in few users (at least 1/100 > > people) and therefore wants the company to suggest and implement ways > > to reduce these effects before an FDA license will be granted for US > > market release. > > > > Will be interesting to see how this one develops. > > > > > > > > ------------------------------------ > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 13, 2008 Report Share Posted December 13, 2008 Based on what I have read about Nebido I wouldn't let them inject my dog with this stuff. Neil JACKPINNER wrote: > > In late 05 or early 06 I was adked if I would like to be in the > Nebido trial. I almost got in but my history of Sleep Apena kept me > out. > After the trial was over I asked the doctor about the results. He > said that it did not work as expected and that it probally would not > reach market in the US. > Jack > > > > From: chrisdl2008 <chrisdl2008@> > > > Subject: Nebido - future market leader? > > > > <mailto: %40> > > > Date: Thursday, 11 December, 2008, 9:12 PM > > > > > > Was reading a book on hypogonadism - Jockenhovel, F., and > Schubert, M. > > > (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty > recent > > > and it stated Nebido will be the standard treatment for > hypogonadism > > > because it has favourable effects with regards to libido, bones > and > > > muscle mass, low incidence of side effects and is more stable > therefore > > > avoiding the peaks and troughs normally seen with shorter acting > > > injectables. > > > > > > Also more acceptable to users because only needs to be injected > 4/5 > > > times a year as opposed to 26-52 times - quite a difference. > Probably > > > its biggest selling point! > > > > > > However since its market launch in 2004 in Europe it does not > seem to > > > be the market leader and I do not hear of many people using it. > Anyone > > > know why this is? > > > > > > Anyone got good/bad experiences on it they can share? > > > > > > I know the FDA is currently working with Indevus Pharmaceuticals > > > (license for Nebido bought from Bayer Schering Pharma) and has > been > > > unhappy with some respiratory side effects in few users (at least > 1/100 > > > people) and therefore wants the company to suggest and implement > ways > > > to reduce these effects before an FDA license will be granted for > US > > > market release. > > > > > > Will be interesting to see how this one develops. > > > > > > > > > > > > ------------------------------------ > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 17, 2008 Report Share Posted December 17, 2008 I for one am glad Nebido exists. It's the only method that does not produce the highs and lows I experienced for 15 years before going onto Nebido. Steph (Glasgow) > > > > From: chrisdl2008 <chrisdl2008@> > > > > Subject: Nebido - future market leader? > > > > > > <mailto: %40> > > > > Date: Thursday, 11 December, 2008, 9:12 PM > > > > > > > > Was reading a book on hypogonadism - Jockenhovel, F., and > > Schubert, M. > > > > (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty > > recent > > > > and it stated Nebido will be the standard treatment for > > hypogonadism > > > > because it has favourable effects with regards to libido, bones > > and > > > > muscle mass, low incidence of side effects and is more stable > > therefore > > > > avoiding the peaks and troughs normally seen with shorter acting > > > > injectables. > > > > > > > > Also more acceptable to users because only needs to be injected > > 4/5 > > > > times a year as opposed to 26-52 times - quite a difference. > > Probably > > > > its biggest selling point! > > > > > > > > However since its market launch in 2004 in Europe it does not > > seem to > > > > be the market leader and I do not hear of many people using it. > > Anyone > > > > know why this is? > > > > > > > > Anyone got good/bad experiences on it they can share? > > > > > > > > I know the FDA is currently working with Indevus Pharmaceuticals > > > > (license for Nebido bought from Bayer Schering Pharma) and has > > been > > > > unhappy with some respiratory side effects in few users (at least > > 1/100 > > > > people) and therefore wants the company to suggest and implement > > ways > > > > to reduce these effects before an FDA license will be granted for > > US > > > > market release. > > > > > > > > Will be interesting to see how this one develops. > > > > > > > > > > > > > > > > ------------------------------------ > > > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 17, 2008 Report Share Posted December 17, 2008 Actually to be fair the muscle waste and arthritis probably started when I was in my early teens. Slow progression has taken it's toll and now I am a wheelchair user because of it. Nebido does work for me. As for it causing insomnia, I've had insomnia since starting on TRT 22 years ago and that was only 150mg every 3 weeks! So, I am not sure that Nebido causes insomnia per se. It certainly doesn't help. However this bad side effect outdoes the benefits such as stable mood, motivation, concentration to name but a few. Too tired to think. As I said in a previous post, Chronic fatigue is one of the conditions associated with Klinefelters. Over- tiredness can also cause insomnia. Steph (Glasgow) > > From: chrisdl2008 <chrisdl2008@> > > Subject: Nebido - future market leader? > > > > Date: Thursday, 11 December, 2008, 9:12 PM > > > > Was reading a book on hypogonadism - Jockenhovel, F., and Schubert, M. > > (2007). `Male hypogonadism'. Uni-Med Science.- which is pretty recent > > and it stated Nebido will be the standard treatment for hypogonadism > > because it has favourable effects with regards to libido, bones and > > muscle mass, low incidence of side effects and is more stable therefore > > avoiding the peaks and troughs normally seen with shorter acting > > injectables. > > > > Also more acceptable to users because only needs to be injected 4/5 > > times a year as opposed to 26-52 times - quite a difference. Probably > > its biggest selling point! > > > > However since its market launch in 2004 in Europe it does not seem to > > be the market leader and I do not hear of many people using it. Anyone > > know why this is? > > > > Anyone got good/bad experiences on it they can share? > > > > I know the FDA is currently working with Indevus Pharmaceuticals > > (license for Nebido bought from Bayer Schering Pharma) and has been > > unhappy with some respiratory side effects in few users (at least 1/100 > > people) and therefore wants the company to suggest and implement ways > > to reduce these effects before an FDA license will be granted for US > > market release. > > > > Will be interesting to see how this one develops. > > > > > > > > ------------------------------------ > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.